Essential Premium

Greenlight Slashes Shorts, But Still Shuns AI Frenzy

Despite boosting its net long exposure, David Einhorn’s hedge fund remains skeptical of the AI rally — warning it could end in major capital destruction.

Tekne Capital’s Beeneet Kothari Plays the Long Game — and Wins Big on China Tech

Tekne Capital’s founder is doubling down on Chinese innovation—betting that the country’s cheap, under-owned tech stocks’ global comeback is just starting.

Sponsored

Why the Commodities Boom Is Different This Time

Biopharma’s Remarkable Reversal of Fortune

Life sciences and biopharma hedge funds have been on a tear for the past few months. Can it continue?

Related Content

Greenlight Capital’s Value-Driven Fund Bucks the Downward Trend

Stephen Taub

One of Venture Capital’s Top Firms Just Raised Its Final Fund. Why Is That So Rare?

Julie Segal

How Wary Asset Managers Learned to Stop Worrying and Embrace Crypto

Leah McGrath Goodman

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram